Skin and Subcutaneous Tissue Bacterial Infections Clinical Trial
Official title:
A Phase 3, Multicenter, Randomized, Double-blind, Active Controlled Study to Evaluate the Efficacy + Safety of IV + Oral Delafloxacin Compared With Vancomycin + Aztreonam in Patients With Acute Bacterial Skin and Skin Structure Infections (ABSSSI)
The purpose of this study is to evaluate the effects of Delafloxacin versus Vancomycin plus Aztreonam in the treatment of patients with acute bacterial skin and soft tissue infections.
The purpose of this study is to determine if delafloxacin, an investigational drug, is safe and effective in the treatment of skin and nearby tissue infections compared with a combination of other antibiotics, vancomycin and aztreonam. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01421511 -
TR-701 FA vs Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infections
|
Phase 3 | |
Active, not recruiting |
NCT02572791 -
Staph Household Intervention for Eradication (SHINE)
|
Phase 4 | |
Completed |
NCT02796716 -
Study of Accuracy of New Diagnostic Technology to Guide Rapid Antibiotic Treatment for Serious Infections
|
N/A | |
Completed |
NCT01283581 -
A Study to Assess Objective Endpoint Measurements of Response in Bacterial Skin Infections
|
Phase 2 | |
Completed |
NCT01519492 -
A Study of Safety, Tolerability, and Efficacy of AFN-12520000 in the Treatment of Acute Bacterial Skin and Skin Structure Infections Due to Staphylococci
|
Phase 2 | |
Completed |
NCT02060513 -
Study of Accuracy of New Diagnostic Technology to Determine Guide Rapid Antibiotic Treatment for Serious Infections
|
N/A | |
Completed |
NCT01170221 -
TR-701 FA vs. Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infections.
|
Phase 3 | |
Completed |
NCT01811732 -
Delafloxacin Versus Vancomycin and Aztreonam for the Treatment of Acute Bacterial Skin and Skin Structure Infections
|
Phase 3 | |
Completed |
NCT03964493 -
TNP-2092 to Treat Acute Bacterial Skin and Skin Structure Infection
|
Phase 2 |